Building on previous work performed by the Cure Alzheimer’s Fund Stem Cell Consortium, Sam Gandy, M.D., Ph.D., at the Icahn School of Medicine at Mt. Sinai conducted studies on a drug called an “mGluR2/3 blocker”, which stimulates the creation of new nerve cells in the brain. Promising pilot results of the drug in mice helped the project secure $1 million in funding from the Veteran’s Administration for additional study.